The Year in Biotech and What’s Ahead in 2023
The Bio Report
00:00
Alzheimer's Drug
Lacanomab is an Alzheimer's drug and development by ASI and Biogen. The magnitude of that benefit is something that is hotly debated, right? There are people who believe that the slowing of the progression of Alzheimer's that we're seeing with Lacanomab is meaningful for patients. You know, these types of amyloid targeting drugs do cause brain bleeds and hemorrhages in the brain called the aria.
Transcript
Play full episode
